MODIGRAF 0.2 mg, granules for oral suspension 50 sachets
Active ingredients: Tacrolimus, Tacrolimus hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspension50 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MODIGRAF 0,2 mg, granulés pour suspension buvable
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 50 sachet(s)-dose(s) aluminium polytéréphtalate (PET) polyéthylène
- Marketing authorisation holder
- ASTELLAS PHARMA EUROPE (PAYS-BAS)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 May 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61092077CIP73959482CIP133400939594828Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TACROLIMUS ANHYDREgranulés | 0,2 mg · un sachet-dose | FT |
| TACROLIMUS MONOHYDRATÉgranulés | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.